Gyre Therapeutics, Inc. Disposal Group, Including Discontinued Operation, Assets, Current
Gyre Therapeutics, Inc. (GYRE) had Disposal Group, Including Discontinued Operation, Assets, Current of $1.53 million as of 2012-12-31, per its 10-Q filed 2013-11-06.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2013-11-06
- 2012-12-31: Disposal Group, Including Discontinued Operation, Assets, Current $1.53M.
| Period end | Disposal Group, Including Discontinued Operation, Assets, Current |
|---|---|
| 2012-12-31 | $1.53M 10-Q · filed 2013-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |